Publikationen in Zusammenarbeit mit Forschern von Royal Brisbane and Women's Hospital (13)

2023

  1. COVID-19 infection in patients on long-term home parenteral nutrition for chronic intestinal failure

    Clinical Nutrition ESPEN, Vol. 55, pp. 212-220

2021

  1. Characteristics of adult patients with chronic intestinal failure due to short bowel syndrome: An international multicenter survey

    Clinical Nutrition ESPEN, Vol. 45, pp. 433-441

  2. Natalizumab, Fingolimod, and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis

    Neurology, Vol. 96, Núm. 24, pp. E2989-E3002

2020

  1. Delay from treatment start to full effect of immunotherapies for multiple sclerosis

    Brain, Vol. 143, Núm. 9, pp. 2742-2756

  2. Home parenteral nutrition provision modalities for chronic intestinal failure in adult patients: An international survey

    Clinical Nutrition, Vol. 39, Núm. 2, pp. 585-591

  3. Intravenous supplementation type and volume are associated with 1-year outcome and major complications in patients with chronic intestinal failure

    Gut, Vol. 69, Núm. 10, pp. 1787-1795

2019

  1. Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study

    Multiple Sclerosis and Related Disorders, Vol. 28, pp. 235-243

  2. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

    npj Breast Cancer, Vol. 5, Núm. 1

2018

  1. Clinical classification of adult patients with chronic intestinal failure due to benign disease: An international multicenter cross-sectional survey

    Clinical Nutrition, Vol. 37, Núm. 2, pp. 728-738

2017

  1. Towards personalized therapy for multiple sclerosis: Prediction of individual treatment response

    Brain, Vol. 140, Núm. 9, pp. 2426-2443

2016

  1. A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae

    Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 7, pp. 4159-4169

2014

  1. Micafungin pharmacokinetic/pharmacodynamic adequacy for the treatment of invasive candidiasis in critically ill patients on continuous venovenous haemofiltration

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 6, pp. 1624-1632

2009

  1. TRIO-012: A multicenter, multinational, randomized, double-blind phase iii study of imc-1121b plus docetaxel versus placebo plus docetaxel in previously untreated patients with her2-negative, unresectable, locally recurrent or metastatic breast cancer

    Clinical Breast Cancer, Vol. 9, Núm. 4, pp. 258-261